Brian Stearns is the founder of Autobahn Therapeutics. Autobahn Therapeutics has raised $176M in total funding. Latest round: Series B.
Brian Stearns, Ph.D., is a Senior Advisor at Autobahn Therapeutics. He has extensive experience in CNS drug discovery, specializing in remyelination. Before joining Autobahn, Dr. Stearns co-founded and served as chief operating officer of Pipeline Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library